Medpace Holdings, Inc. (MEDP)
Medpace Holdings, Inc. (MEDP) from its SEC filings: 2025 revenue $2.5 billion (+20% vs the year before), net margin 18%, free cash flow $681.9 million. Insider trades, recent filings and a price chart. Free.
| Exchange | Nasdaq |
| Industry | Services-Commercial Physical & Biological Research |
| Revenue (2025) | $2.5 billion |
| Revenue growth | +20% |
| Net income | $451.1 million |
| Net margin | 17.8% |
| Free cash flow | $681.9 million |
| Diluted EPS | $15.28 |
| Latest quarter (Q3 2026 (calendar)) revenue vs a year earlier | +8% |
| Cash | $705.3 million |
| Long-term debt | $0 |
| Share count, 1 year | -1% |
| Fundamentals check | Strong fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-23. Education only, not financial advice.